COVID-19 Outcomes Among Adults Receiving Electronic Nudges to Increase Influenza Vaccination
This secondary analysis of a randomized clinical trial investigates whether electronic nudging letters to increase influenza vaccination have an effect on COVID-19 vaccination, infection, and hospitalization.
Authors
- Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
- Deepak L. Bhatt (ORCID: https://orcid.org/0000-0002-1278-6245)
- Erica Dueger (ORCID: https://orcid.org/0000-0001-6404-3163)
- Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
- Niklas Dyrby Johansen (ORCID: https://orcid.org/0000-0001-6959-3236)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Scott Solomon
Institutions
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- Steno Diabetes Centers (DK)
- Harvard University (US)
- Gentofte Hospital (DK)
- Sanofi (France) (FR)
- Kaiser Permanente San Francisco Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.0320
- Primary Topic
- Mobile Health and mHealth Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Pfizer
- AstraZeneca
- Bayer
- Sanofi
- Boston Scientific Corporation
- Impulse Dynamics
- Novo Nordisk
- Seqirus
- Sanofi Pasteur
- American Regent